0
0
12/20/25 at 1:37pm
Organization
CNBC
Author
Lisa Kailai Han
40 words
0
Comments
Based on its 12-month price target, Mizuho sees shares of Vaxcyte soaring almost 300% from current levels.
You are the first to view
https://www.cnbc.com/2025/12/20/wall-streets-top-stock-picks-for-2026-mizuhos-under-the-radar-name.html
Create an account
or login to join the discussion